do not combine dpp-4 inhibitors with glp-1 receptor agonists recommendation and GLP-1RAs: cardiovascular safety and benefits GLP-1-based therapies for type 2

Prior authorizations, insurance rejections, and coverage clarifications are more frequent for obesity indications

GLP-1 drugs, such as Ozempic and other medications used to treat type 2 diabetes and obesity, are becoming increasingly popular due to their effectiveness in managing blood sugar levels and promoting weight loss

[PubMed] [Google Scholar] 170.Stern J.H., Smith G.I., Chen S., Unger R.H., Klein S., Scherer P.E

as well as in regions protected by the bloodbrain barrier: arcuate hypothalamic nucleus, nucleus of the solitary tract, and the dorsal motor nucleus of the vagus nerve (Fig

This can result in symptoms like bloating, diarrhea, and abdominal pain

Neuronal gastrin-releasing peptide in the mammalian gut and pancreas